Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Chamberlain

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Neurosurgery|October 25, 2014
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewLeland Rogers, Igor Barani, Marc Chamberlain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet!Agnieszka Korfel, Marc Chamberlain, Ed Neuwelt, et al.
Journal of Neuro-Oncology|January 23, 2014
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomasJeffrey J Raizer, Sean A Grimm, Alfred Rademaker, et al.
JAMA Oncology|June 30, 2018
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical TrialVirginia F Borges, Cristiano Ferrario, Nathalie Aucoin, et al.
Seminars in Oncology|June 29, 2013
A 60-year-old Indian male with altered sensorium and extensive lymphoma of the scalpBudhi S Yadav, Anshuma Bansal, Suresh C Sharma, et al.
Neuro-Oncology|October 11, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapyPatrick Y Wen, Jan Drappatz, John de Groot, et al.
Neuro-Oncology|October 17, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapyTimothy F Cloughesy, Jan Drappatz, John de Groot, et al.
Neuro-Oncology|May 29, 2014
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trialsMarc Chamberlain, Riccardo Soffietti, Jeffrey Raizer, et al.
Neuro-Oncology|January 1, 2017
Leptomeningeal metastases: a RANO proposal for response criteriaMarc Chamberlain, Larry Junck, Dieta Brandsma, et al.
Neuro-Oncology Advances|December 23, 2024
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade gliomaCrismita Dmello, Andrew Brenner, David Piccioni, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Neurosurgery|October 25, 2014
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewLeland Rogers, Igor Barani, Marc Chamberlain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Therapy for Secondary CNS Involvement in Malignant Lymphomas: No Standard Yet!Agnieszka Korfel, Marc Chamberlain, Ed Neuwelt, et al.
Journal of Neuro-Oncology|January 23, 2014
A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomasJeffrey J Raizer, Sean A Grimm, Alfred Rademaker, et al.
JAMA Oncology|June 30, 2018
Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical TrialVirginia F Borges, Cristiano Ferrario, Nathalie Aucoin, et al.
Seminars in Oncology|June 29, 2013
A 60-year-old Indian male with altered sensorium and extensive lymphoma of the scalpBudhi S Yadav, Anshuma Bansal, Suresh C Sharma, et al.
Neuro-Oncology|October 11, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapyPatrick Y Wen, Jan Drappatz, John de Groot, et al.
Neuro-Oncology|October 17, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapyTimothy F Cloughesy, Jan Drappatz, John de Groot, et al.
Neuro-Oncology|May 29, 2014
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trialsMarc Chamberlain, Riccardo Soffietti, Jeffrey Raizer, et al.
Neuro-Oncology|January 1, 2017
Leptomeningeal metastases: a RANO proposal for response criteriaMarc Chamberlain, Larry Junck, Dieta Brandsma, et al.
Neuro-Oncology Advances|December 23, 2024
Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade gliomaCrismita Dmello, Andrew Brenner, David Piccioni, et al.
Pageof 4